In the medicines safety community, one would need to be living under a rock not to have read a great deal about deprescribing by now. Less attention has been devoted to diagnoses, which allow clinicians to make sensible prescribing decisions. In a new slant, the term undiagnosis has been coined to provide a framework for further consideration of this matter. In an interesting discussion (more here), it has been proposed that some diagnoses don’t necessarily attract a need for treatment, as this may create harm without potential benefit. In this discussion it is proposed that diagnoses need to be reviewed periodically – in fact investigations and diagnoses can lead to overdiagnosis, and other factors such as broadening disease definitions and medicolegal apprehension can be drivers. The term undiagnosis, this process facilitates the withdrawal of some medicines. Systematically reviewing diagnoses regularly offers the prospect of reduced prescribing. The authors describe a novel mnemonic: ERASE – Evaluate diagnoses to consider Resolved conditions, Ageing normally and Selecting appropriate targets to Eliminate unnecessary diagnoses and their corresponding medicines. This concept appears to be destined for greater consideration in the future.
Recent Posts
Archives
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018